{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:43:04Z","timestamp":1777027384493,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.drugalcdep.2012.08.009","type":"journal-article","created":{"date-parts":[[2012,9,9]],"date-time":"2012-09-09T06:15:07Z","timestamp":1347171307000},"page":"90-97","source":"Crossref","is-referenced-by-count":31,"title":["The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial"],"prefix":"10.1016","volume":"128","author":[{"given":"Bruce R.","family":"Schackman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Metsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant N.","family":"Colfax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared A.","family":"Leff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callie A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Feaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Gooden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle P.","family":"Walensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.300.8.945","article-title":"Opt-out testing for human immunodeficiency virus in the United States: progress and challenges","volume":"300","author":"Bartlett","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0015","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsat.2006.02.006","article-title":"Characteristics of substance abuse treatment programs providing services for HIV\/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network","volume":"30","author":"Brown","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0272989X9401400308","article-title":"Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment","volume":"14","author":"Cantor","year":"1994","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0040","first-page":"1051","article-title":"Approval of a new rapid test for HIV antibody","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0030","first-page":"133","article-title":"HIV infection and HIV-associated behaviors among injecting drug users \u2013 20 cities, United States, 2009","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1370\/afm.375","article-title":"The cost-effectiveness of expanded testing for primary HIV infection","volume":"3","author":"Coco","year":"2005","journal-title":"Ann. Family Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMsa054744","article-title":"The value of medical spending in the United States, 1960\u20132000","volume":"355","author":"Cutler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0050","doi-asserted-by":"crossref","first-page":"e11068","DOI":"10.1371\/journal.pone.0011068","article-title":"Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco","volume":"5","author":"Das","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0055","series-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents","author":"Department of Health and Human Services","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0060","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":"The cost effectiveness of combination antiretroviral therapy for HIV disease","volume":"344","author":"Freedberg","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.aids.0000161772.51900.eb","article-title":"Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care","volume":"19","author":"Gardner","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0080","series-title":"Cost Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/QAI.0b013e31825bd862","article-title":"Cost-effectiveness of the National HIV\/AIDS Strategy (NHAS) goal of increasing linkage to care for HIV-infected persons","volume":"61","author":"Gopalappa","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0090","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(07)60597-2","article-title":"Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial","volume":"369","author":"Grinsztejn","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0095","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1086\/425743","article-title":"The case for earlier treatment of HIV infection","volume":"39","author":"Holmberg","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0100","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pmed.0040194","article-title":"Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing","volume":"4","author":"Holtgrave","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.aids.0000166091.39317.99","article-title":"Atazanavir plus ritonavir or saquinavir, and lopinavir\/ritonavir in patients experiencing multiple virological failures","volume":"19","author":"Johnson","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0110","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/jama.285.18.2355","article-title":"Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs","volume":"285","author":"Laine","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0115","series-title":"14th Annual Conference on Retroviruses and Opportunistic Infections","article-title":"Efficacy and safety of maraviroc plus optimized background therapy in viremic ART experienced patients infected with CCR5-tropic HIV-1: 24-week results of a phase 2b\/3 study in the US and Canada","author":"Lalezari","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0120","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/644772","article-title":"Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy","volume":"49","author":"Losina","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09540120412331305098","article-title":"Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence","volume":"17","author":"Mannheimer","year":"2005","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.qai.0000151079.33935.79","article-title":"Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs","volume":"39","author":"Marks","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.olq.0000151421.97004.c0","article-title":"Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2)","volume":"32","author":"Metcalf","year":"2005","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0140","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2105\/AJPH.2011.300460","article-title":"Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial","volume":"102","author":"Metsch","year":"2012","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0145","series-title":"Cohort Study (MACS) Public Dataset: Release PO4","author":"Multicenter AIDS","year":"1995"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.qai.0000185314.56556.c3","article-title":"Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials","volume":"40","author":"Nelson","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0155","series-title":"National HIV\/AIDS Strategy for the United States","author":"Office of National AIDS Policy","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States\u2014an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-145-11-200612050-00004","article-title":"Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs","volume":"145","author":"Paltiel","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsat.2009.12.004","article-title":"HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995\u20132005","volume":"38","author":"Pollack","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.08.009_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/00333549101250S111","article-title":"Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial","volume":"125","author":"Ruger","year":"2010","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMsa042657","article-title":"Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy","volume":"352","author":"Sanders","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0272989X0202200103","article-title":"Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV\/AIDS","volume":"22","author":"Schackman","year":"2002","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0190","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/01.mlr.0000228021.89490.2a","article-title":"The lifetime cost of current human immunodeficiency virus care in the United States","volume":"44","author":"Schackman","year":"2006","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0195","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/QAD.0b013e3283103ce6","article-title":"The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV","volume":"22","author":"Schackman","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","article-title":"Cost-effectiveness of long-term outpatient buprenorphine\u2013naloxone treatment for opioid dependence in primary care","volume":"27","author":"Schackman","year":"2012","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/phr\/118.1.37","article-title":"On-site HIV testing in residential drug treatment units: results of a nationwide survey","volume":"118","author":"Strauss","year":"2003","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn\u2019t it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjmed.2004.07.055","article-title":"Routine human immunodeficiency virus testing: an economic evaluation of current guidelines","volume":"118","author":"Walensky","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.08.009_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States","volume":"194","author":"Walensky","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.drugalcdep.2012.08.009_bib0225","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/522546","article-title":"Cost-effectiveness of HIV testing and treatment in the United States","volume":"45","author":"Walensky","year":"2007","journal-title":"Clin. Infect. Dis."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612003262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:26:07Z","timestamp":1562156767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612003262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0376871612003262"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.08.009","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}